{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T09:27:40Z","timestamp":1780824460004,"version":"3.54.1"},"reference-count":40,"publisher":"Walter de Gruyter GmbH","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ebola virus, an enveloped virus, is the cause of the largest and most complex Ebola virus disease (EVD) outbreak in West Africa. Blood or body fluids of an infected person may represent a biohazard to laboratory workers. Laboratory tests of virus containing specimens should be conducted in referral centres at biosafety level 4, but based on the severity of clinical symptoms, basic laboratories might be required to execute urgent tests for patients suspected of EVD. The aim of this work was to compare the analytical performances of laboratory tests when Triton X-100, a chemical agent able to inactivate other enveloped viruses, was added to specimens.<\/jats:p><jats:p>Results of clinical chemistry, coagulation and haematology parameters on samples before and after the addition of 0.1% (final concentration) of Triton X-100 and 1 h of incubation at room temperature were compared.<\/jats:p><jats:p>Overall, results showed very good agreement by all statistical analyses. Triton X-100 at 0.1% did not significantly affect the results for the majority of the analytes tested.<\/jats:p><jats:p>Triton X-100 at 0.1% can be used to reduce the biohazard in performing laboratory tests on samples from patients with EVD without affecting clinical decisions.<\/jats:p>","DOI":"10.1515\/cclm-2015-0119","type":"journal-article","created":{"date-parts":[[2015,6,10]],"date-time":"2015-06-10T20:08:20Z","timestamp":1433966900000},"source":"Crossref","is-referenced-by-count":15,"title":["Diagnostic performances of clinical laboratory tests using Triton X-100 to reduce the biohazard associated with routine testing of Ebola virus-infected patients"],"prefix":"10.1515","volume":"53","author":[{"given":"Massimo","family":"Tempestilli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigia","family":"Pucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Notari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino Di","family":"Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Castilletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Rivelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Agrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo Paolo","family":"Pucillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","reference":[{"key":"ref221","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"ref291","first-page":"05","article-title":"Centers for Disease Control and Prevention Interim guidance for managing patients with suspected viral hemorrhagic fever in US hospitals Available from : http www cdc gov HAI pdfs bbp VHFinterimGuidance pdf Accessed","author":"December","year":"2014"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/BF01962603","article-title":"Inactivation of human immunodeficiency virus in serum specimens as a safety measure for diagnostic immunoassays","volume":"23","author":"Ukkonen","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref61","article-title":"Centers for Disease Control and Prevention Interim guidance for specimen collection transport testing and submission for persons under investigation for Ebola virus disease in the United States Available from : http www cdc gov vhf ebola hcp interim","year":"2014"},{"key":"ref361","first-page":"37","article-title":"Effects of heating plasma at degrees for min and at degrees for min on routine biochemistry analytes","author":"Bhagat","year":"2000","journal-title":"Ann Clin Biochem"},{"key":"ref271","first-page":"182","article-title":"Laboratory preparedness to face infectious outbreaks Ebola beyond","author":"Lippi","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"ref391","first-page":"38","article-title":"The use of solvent \/ detergent treatment in pathogen reduction of plasma","author":"Hellstern","year":"2011","journal-title":"Med"},{"key":"ref71","first-page":"182","article-title":"Laboratory preparedness to face infectious outbreaks Ebola beyond","author":"Lippi","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"ref261","article-title":"Centers for Disease Control and Prevention Interim guidance for specimen collection transport testing and submission for persons under investigation for Ebola virus disease in the United States Available from : http www cdc gov vhf ebola hcp interim","year":"2014"},{"key":"ref211","article-title":"for Disease Control and Prevention Available from http www cdc gov vhf ebola Accessed","author":"Centers","year":"2014"},{"key":"ref231","first-page":"6305","article-title":"Fifteen countries are at risk of Ebola outbreak says WHO","volume":"17","author":"Gulland","year":"2014","journal-title":"Med"},{"key":"ref191","first-page":"38","article-title":"The use of solvent \/ detergent treatment in pathogen reduction of plasma","author":"Hellstern","year":"2011","journal-title":"Med"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1373\/clinchem.2004.031666","article-title":"von Influence of practicable virus inactivation procedures on tests for frequently measured analytes in plasma","author":"Hersberger","year":"2004","journal-title":"Clin Chem"},{"key":"ref301","article-title":"Ontario Agency for Protection Promotion Available from http www publichealthontario ca en eRepository Ebola Virus Disease Sample Collection Submission Guide pdf Accessed","author":"December","year":"2014","journal-title":"Health"},{"key":"ref01","first-page":"411","article-title":"of the viral hemorrhagic fevers","volume":"24","author":"Paessler","year":"2013","journal-title":"Annu Rev"},{"key":"ref241","first-page":"12","article-title":"Infection control management of patients with suspected highly infectious diseases in emergency departments : data from a survey in facilities in European countries","volume":"41","author":"Fusco","year":"2012","journal-title":"BMC Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"ref341","article-title":"Infection prevention and control guidance for care of patients in health - care settings with focus on Ebola Available from http www who int csr resources publications ebola filovirus infection control en Accessed December","year":"2014","journal-title":"Word Health Organization"},{"key":"ref11","article-title":"for Disease Control and Prevention Available from http www cdc gov vhf ebola Accessed","author":"Centers","year":"2014"},{"key":"ref351","article-title":"NYC laboratory guidelines for handling specimens from patients with suspected or confirmed Ebola virus disease Available from https www health ny gov diseases communicable ebola docs lab guidelines pdf Accessed","author":"December","year":"2014"},{"key":"ref41","first-page":"12","article-title":"Infection control management of patients with suspected highly infectious diseases in emergency departments : data from a survey in facilities in European countries","volume":"41","author":"Fusco","year":"2012","journal-title":"BMC Infect Dis"},{"key":"ref171","first-page":"2015","article-title":"Kit Evaluation of Ebola virus inactivation procedures for Plasmodium falciparum malaria diagnostics","author":"Lau","journal-title":"J Clin Microbiol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1111\/trf.12913","article-title":"Ebola virus disease transmission risk to laboratory personnel and pretransfusion testing","author":"Katz","year":"2014","journal-title":"Transfusion"},{"key":"ref161","first-page":"37","article-title":"Effects of heating plasma at degrees for min and at degrees for min on routine biochemistry analytes","author":"Bhagat","year":"2000","journal-title":"Ann Clin Biochem"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/BF01962603","article-title":"Inactivation of human immunodeficiency virus in serum specimens as a safety measure for diagnostic immunoassays","volume":"23","author":"Ukkonen","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref201","first-page":"411","article-title":"of the viral hemorrhagic fevers","volume":"24","author":"Paessler","year":"2013","journal-title":"Annu Rev"},{"key":"ref91","first-page":"05","article-title":"Centers for Disease Control and Prevention Interim guidance for managing patients with suspected viral hemorrhagic fever in US hospitals Available from : http www cdc gov HAI pdfs bbp VHFinterimGuidance pdf Accessed","author":"December","year":"2014"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1373\/clinchem.2004.031666","article-title":"von Influence of practicable virus inactivation procedures on tests for frequently measured analytes in plasma","author":"Hersberger","year":"2004","journal-title":"Clin Chem"},{"key":"ref31","first-page":"6305","article-title":"Fifteen countries are at risk of Ebola outbreak says WHO","volume":"17","author":"Gulland","year":"2014","journal-title":"Med"},{"key":"ref51","first-page":"165","article-title":"Risk management of febrile respiratory illness in emergency departments","volume":"31","author":"Puro","year":"2008","journal-title":"New Microbiol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1128\/JCM.20.3.486-489.1984","article-title":"Physicochemical inactivation of Lassa Ebola and Marburg viruses and effect on clinical laboratory analyses","volume":"20","author":"Mitchell","year":"1984","journal-title":"J Clin Microbiol"},{"key":"ref251","first-page":"165","article-title":"Risk management of febrile respiratory illness in emergency departments","volume":"31","author":"Puro","year":"2008","journal-title":"New Microbiol"},{"key":"ref151","article-title":"NYC laboratory guidelines for handling specimens from patients with suspected or confirmed Ebola virus disease Available from https www health ny gov diseases communicable ebola docs lab guidelines pdf Accessed","author":"December","year":"2014"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jhin.2012.04.019","article-title":"Infection control practices in facilities for highly infectious diseases across Europe","author":"Maltezou","year":"2012","journal-title":"J Hosp Infect"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1111\/trf.12913","article-title":"Ebola virus disease transmission risk to laboratory personnel and pretransfusion testing","author":"Katz","year":"2014","journal-title":"Transfusion"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1128\/JCM.20.3.486-489.1984","article-title":"Physicochemical inactivation of Lassa Ebola and Marburg viruses and effect on clinical laboratory analyses","volume":"20","author":"Mitchell","year":"1984","journal-title":"J Clin Microbiol"},{"key":"ref101","article-title":"Ontario Agency for Protection Promotion Available from http www publichealthontario ca en eRepository Ebola Virus Disease Sample Collection Submission Guide pdf Accessed","author":"December","year":"2014","journal-title":"Health"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jhin.2012.04.019","article-title":"Infection control practices in facilities for highly infectious diseases across Europe","author":"Maltezou","year":"2012","journal-title":"J Hosp Infect"},{"key":"ref371","first-page":"2015","article-title":"Kit Evaluation of Ebola virus inactivation procedures for Plasmodium falciparum malaria diagnostics","author":"Lau","journal-title":"J Clin Microbiol"},{"key":"ref141","article-title":"Infection prevention and control guidance for care of patients in health - care settings with focus on Ebola Available from http www who int csr resources publications ebola filovirus infection control en Accessed December","year":"2014","journal-title":"Word Health Organization"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2015-0119\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T23:48:53Z","timestamp":1619048933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2015-0119\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,1]]},"references-count":40,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.1515\/cclm-2015-0119","relation":{},"ISSN":["1437-4331","1434-6621"],"issn-type":[{"value":"1437-4331","type":"electronic"},{"value":"1434-6621","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1,1]]}}}